MusclePharm Supporting Clinical Research

DENVERMusclePharm Corp. (OTCBB: MSLP) announced it has entered a multi-year clinical research program with the Metabolic and Body Composition Laboratory in the University of Oklahomas (OU) Department of Health and Exercise Science to study the effects of the companys products. Jeffrey R. Stout, Ph.D., an associate professor and director of the OU lab and a scientific advisor to MusclePharm, will lead the clinical research program, which will study the effects of MusclePharms products on high-intensity interval training, on aerobic and anaerobic power, repeated sprint ability, body composition and training volume.

"We are excited to be working with the University of Oklahoma and such an esteemed team focused on health and exercise science to further understand the results of MusclePharm products," said Brad Pyatt, CEO, MusclePharm. "As one of the leading developers of nutritional supplements, we continue to focus on safe and scientific product formulations that will benefit the global healthy living and wellness industry as we strive to increase sales and profitability long-term."